Exhibition · Newbury, United Kingdom
BioTrinity 2013
Biotechnology · Biochemistry
Key numbers
- Editions on record
- 5first in 2009
About BioTrinity
BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other European partnering conference. Check out who else is coming, including over 70 investment firms confirmed, and what they say about BioTrinity, the expert discussion panels, and which more than 70 companies will be presenting in the showcase. Don't miss out:
Meet the key licensing contacts from big pharma including Abbott, Amgen, Astellas, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Eli Lilly, Genzyme, GSK, Goldshield Group, Merck & Co., Novartis, Shire, Takeda, Teijin and Teva and other senior BD&L execs
Meet 100 delegates from active VC and Corporate Venture firms including MedImmune Ventures, SR One, Shire Strategic Investment, Merck Serono Ventures, Merck Research Ventures, Abbott Biotech Ventures, Astellas Venture Management, and Boehringer Ingelheim Ventures and many international VCs
Meet a hand-picked crop of early-stage companies you haven't seen elsewhere
Meet the senior execs who can complete the value chain for your business
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 12–14 May 2014 | Novotel London West London, United Kingdom | — | — |
| 2013 | 14–16 May 2013 | Newbury Racecourse Newbury, United Kingdom | — | — |
| 2012 | 24–26 Apr 2012 | Newbury Racecourse Newbury, United Kingdom | — | — |
| 2011 | 12–14 Apr 2011 | Newbury Racecourse Newbury, United Kingdom | — | — |
| 2010 | 12–14 Apr 2010 | Kassam Stadium Oxford, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.